JFNCX
Price
$54.14
Change
+$2.35 (+4.54%)
Updated
Apr 9 closing price
Net Assets
4.71B
SHSAX
Price
$61.25
Change
+$2.67 (+4.56%)
Updated
Apr 9 closing price
Net Assets
6.74B
Ad is loading...

JFNCX vs SHSAX

Header iconJFNCX vs SHSAX Comparison
Open Charts JFNCX vs SHSAXBanner chart's image
Janus Henderson Global Life Sciences C
Price$54.14
Change+$2.35 (+4.54%)
VolumeN/A
Net Assets4.71B
BlackRock Health Sciences Opps Inv A
Price$61.25
Change+$2.67 (+4.56%)
VolumeN/A
Net Assets6.74B
JFNCX vs SHSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFNCX vs. SHSAX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNCX is a Hold and SHSAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 6.74B vs. JFNCX (4.71B). SHSAX pays higher dividends than JFNCX: SHSAX (0.21) vs JFNCX (0.00). JFNCX was incepted earlier than SHSAX: JFNCX (16 years) vs SHSAX (25 years). JFNCX (1.76) is less costly to investors than SHSAX (1.09). JFNCX is a more actively managed with annual turnover of: 35.00 vs. SHSAX (27.00). SHSAX has a lower initial minimum investment than JFNCX: SHSAX (1000) vs JFNCX (2500). SHSAX annual gain was more profitable for investors over the last year : -15.09 vs. JFNCX (-16.59). JFNCX return over 5 years is better than : 4.65 vs. SHSAX (-3.19).
JFNCXSHSAXJFNCX / SHSAX
Total Expense Ratio1.761.09161%
Annual Report Gross Expense Ratio1.761.09161%
Fund Existence16 years25 years-
Gain YTD-9.315-6.182151%
Front LoadN/A5%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets4.71B6.74B70%
Annual Yield % from dividends0.000.21-
Returns for 1 year-16.59-15.09110%
Returns for 3 years-13.07-20.0765%
Returns for 5 years4.65-3.19-146%
Returns for 10 years-10.627.78-137%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTPIX36.29N/A
N/A
ProFunds NASDAQ-100 Inv
VWUSX57.11N/A
N/A
Vanguard US Growth Investor
FFEFX12.76N/A
N/A
Nuveen Dividend Value R6
SMDVX15.49N/A
N/A
Hartford Schroders US MidCap Opps A
PSVKX13.61N/A
N/A
PGIM Quant Solutions Small-Cap Val R4